Furthermore, we found highly suggestive evidence between higher CRP and risk of CHD, type 2 diabetes and mortality or CVD on stable CAD patients and on unstable CHD/ACS/angina patients. This evidence concerns the gene CRP and type 2 diabetes mellitus.